51 – 60 of 358
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Converging pathways in pulmonary fibrosis and Covid-19 - The fibrotic link to disease severity : Common molecular pathways in Covid-19 and pulmonary fibrosis
(
- Contribution to journal › Article
-
Mark
Salbutamol use in relation to maintenance bronchodilator efficacy in COPD : a prospective subgroup analysis of the EMAX trial
(
- Contribution to journal › Article
-
Mark
Type 2 inflammatory biomarker response after exercise challenge testing
(
- Contribution to journal › Article
-
Mark
International severe asthma registry (ISAR) : protocol for a global registry
(
- Contribution to journal › Article
-
Mark
VEGF synthesis and VEGF receptor 2 expression in patients with bronchiolitis obliterans syndrome after lung transplantation
(
- Contribution to journal › Article
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
(
- Contribution to journal › Letter
-
Mark
Eosinophils, basophils, and type 2 immune microenvironments in COPD-affected lung tissue
(
- Contribution to journal › Article
-
Mark
Clinical and daily respiratory care and clinical trials within the COVID-19 era
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD : a post hoc analysis of the EMAX randomised controlled trial
(
- Contribution to journal › Article
-
Mark
The risk of osteoporosis in patients with asthma
(
- Contribution to journal › Scientific review